These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 17362834

  • 1. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
    McKeith I, O'Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, Padovani A, Giubbini R, Bonuccelli U, Volterrani D, Holmes C, Kemp P, Tabet N, Meyer I, Reininger C, DLB Study Group.
    Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
    [Abstract] [Full Text] [Related]

  • 2. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
    McCleery J, Morgan S, Bradley KM, Noel-Storr AH, Ansorge O, Hyde C.
    Cochrane Database Syst Rev; 2015 Jan 30; 1(1):CD010633. PubMed ID: 25632881
    [Abstract] [Full Text] [Related]

  • 3. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.
    Walker Z, Jaros E, Walker RW, Lee L, Costa DC, Livingston G, Ince PG, Perry R, McKeith I, Katona CL.
    J Neurol Neurosurg Psychiatry; 2007 Nov 30; 78(11):1176-81. PubMed ID: 17353255
    [Abstract] [Full Text] [Related]

  • 4. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
    Colloby SJ, Firbank MJ, Pakrasi S, Lloyd JJ, Driver I, McKeith IG, Williams ED, O'Brien JT.
    Int Psychogeriatr; 2008 Dec 30; 20(6):1124-40. PubMed ID: 18752700
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies.
    Tang Z, Hirano S, Koizumi Y, Izumi M, Kitayama Y, Yamagishi K, Tamura M, Ishikawa A, Kashiwado K, Iimori T, Mukai H, Yokota H, Horikoshi T, Uno T, Kuwabara S.
    J Alzheimers Dis; 2024 Dec 30; 100(1):127-137. PubMed ID: 38848178
    [Abstract] [Full Text] [Related]

  • 6. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
    Tiraboschi P, Corso A, Guerra UP, Nobili F, Piccardo A, Calcagni ML, Volterrani D, Cecchin D, Tettamanti M, Antelmi L, Vidale S, Sacco L, Merello M, Stefanini S, Micheli A, Vai P, Capitanio S, Gabanelli SV, Riva R, Pinto P, Biffi AM, Muscio C, SCILLA Working Group.
    Ann Neurol; 2016 Sep 30; 80(3):368-78. PubMed ID: 27398636
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An 123I-FP-CIT SPECT study.
    Joling M, Vriend C, Raijmakers PGHM, van der Zande JJ, Lemstra AW, Berendse HW, Booij J, van den Heuvel OA.
    Neuroimage Clin; 2019 Sep 30; 22():101755. PubMed ID: 30884365
    [Abstract] [Full Text] [Related]

  • 9. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S, Hirao K, Kanetaka H, Namioka N, Hatanaka H, Hirose D, Fukasawa R, Umahara T, Sakurai H, Hanyu H.
    Eur J Nucl Med Mol Imaging; 2016 Jan 30; 43(1):184-192. PubMed ID: 26233438
    [Abstract] [Full Text] [Related]

  • 10. [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies.
    van der Zande JJ, Booij J, Scheltens P, Raijmakers PG, Lemstra AW.
    Eur J Nucl Med Mol Imaging; 2016 Jun 30; 43(6):1060-6. PubMed ID: 26830298
    [Abstract] [Full Text] [Related]

  • 11. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.
    Morgan S, Kemp P, Booij J, Costa DC, Padayachee S, Lee L, Barber C, Carter J, Walker Z.
    J Neurol Neurosurg Psychiatry; 2012 Nov 30; 83(11):1063-70. PubMed ID: 22869921
    [Abstract] [Full Text] [Related]

  • 12. Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An 123I-FP-CIT SPECT study.
    van der Zande JJ, Joling M, Happach IG, Vriend C, Scheltens P, Booij J, Lemstra AW.
    Neuroimage Clin; 2020 Nov 30; 25():102062. PubMed ID: 31790878
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies.
    Walker Z, Cummings JL.
    Alzheimers Dement; 2012 Jan 30; 8(1):74-83. PubMed ID: 22024052
    [Abstract] [Full Text] [Related]

  • 15. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and 123 I-metaiodobenzylguanidine myocardial scintigraphy for the diagnosis of dementia with Lewy bodies.
    Kobayashi S, Makino K, Hatakeyama S, Ishii T, Tateno M, Iwamoto T, Tsujino H, Kawasaki K, Mikuni K, Ukai W, Murayama T, Hashimoto E, Utsumi K, Kawanishi C.
    Psychogeriatrics; 2017 Jul 30; 17(4):247-255. PubMed ID: 28130808
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies.
    Thomas AJ, Donaghy P, Roberts G, Colloby SJ, Barnett NA, Petrides G, Lloyd J, Olsen K, Taylor JP, McKeith I, O'Brien JT.
    Psychol Med; 2019 Feb 30; 49(3):396-402. PubMed ID: 29692275
    [Abstract] [Full Text] [Related]

  • 17. 123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias.
    Brigo F, Turri G, Tinazzi M.
    J Neurol Sci; 2015 Dec 15; 359(1-2):161-71. PubMed ID: 26671107
    [Abstract] [Full Text] [Related]

  • 18. Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.
    Thomas AJ, Attems J, Colloby SJ, O'Brien JT, McKeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z.
    Neurology; 2017 Jan 17; 88(3):276-283. PubMed ID: 27940650
    [Abstract] [Full Text] [Related]

  • 19. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.
    Walker Z, Costa DC, Walker RW, Lee L, Livingston G, Jaros E, Perry R, McKeith I, Katona CL.
    Neurology; 2004 May 11; 62(9):1568-72. PubMed ID: 15136683
    [Abstract] [Full Text] [Related]

  • 20. Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies.
    Taylor JP, Colloby SJ, McKeith IG, Burn DJ, Williams D, Patterson J, O'Brien JT.
    J Neurol Neurosurg Psychiatry; 2007 Oct 11; 78(10):1069-71. PubMed ID: 17299017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.